.

ISSN 2063-5346
For urgent queries please contact : +918130348310

IMPACT OF CLINICAL PHARMACIST’S INTERVENTION IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS: A COMPARATIVE STUDY

Main Article Content

Shanmugapriya.S.K1 , Shashank.K1 , Subashini.S1 , Sujitha.G.S1 , Ashok Kumar.T.R2 , Dr. Karthikeyan. K3 , Dr. Shanmugasundaram. P
» doi: 10.31838/ecb/2023.12.s1-B.471

Abstract

Background: Diabetes is the one of the most prevalent metabolic disorder. At present, pharmacological therapy alone is considered for the treatment which results in higher possibility of adverse effect development with lesser expected benefit. Clinical pharmacist plays an important role in the reducing the possibility of developing the undesired event by analysing the prescription and also in framing the Medical Nutritional Therapy by considering the patient’s preferences and dietician’s recommendation. MNT is important as it can reduce the need for large number of medications to achieve the glycaemic control. This study is conducted as an attempt to emphasize the impact of clinical pharmacist’s intervention in the management of Type 2 Diabetes Mellitus AIM: The main aim of the study is to emphasize the role of clinical pharmacist’s intervention in the management of Type 2 Diabetes Mellitus OBJECTIVE: The primary objective is to achieve euglycemia and to reduce the HbA1C levels of the patients recruited in the study. The secondary objective is to reduce the possibility of developing any undesired effects in the patients recruited in the study. RESULTS: 30 patients were recruited in both test and control group (60 in total). Mean of the FBG and PPBG of the test patients before intervention were 190.53 mg/dl and 311.43 mg/dl respectively. Mean of FBG and PPBG of the test patients after intervention were 128.8 mg/dl and 184.3 mg/dl respectively. Mean of the FBG and PPBG of the control group patients before interventions were 197.8 mg/dl and 309.9 mg/dl respectively. Mean of the FBG and PPBG of the control group after intervention were 187.9 mg/dl and 288.6 mg/dl respectively. Mean with standard deviation of the HbA1c of the test group before intervention was 8.64 + 0.8 and after intervention was 7.37 + 0.52 respectively. Mean with standard deviation of HbA1c of the control group before intervention was 8.91 + 1.06 and after the intervention phase the mean with standard deviation was found to be 8.65 + 1.03 respectively

Article Details